X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Piramal Healthcare with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs SUN PHARMA - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES SUN PHARMA PIRAMAL ENTERPRISES/
SUN PHARMA
 
P/E (TTM) x 29.0 32.8 88.4% View Chart
P/BV x 1.3 2.7 47.5% View Chart
Dividend Yield % 1.4 0.5 295.4%  

Financials

 PIRAMAL ENTERPRISES   SUN PHARMA
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
SUN PHARMA
Mar-18
PIRAMAL ENTERPRISES/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs3,303701 471.5%   
Low Rs1,797433 414.8%   
Sales per share (Unadj.) Rs716.5110.4 648.9%  
Earnings per share (Unadj.) Rs79.711.0 726.1%  
Cash flow per share (Unadj.) Rs107.917.2 626.3%  
Dividends per share (Unadj.) Rs28.002.00 1,400.0%  
Dividend yield (eoy) %1.10.4 311.2%  
Book value per share (Unadj.) Rs1,477.5158.8 930.4%  
Shares outstanding (eoy) m184.452,399.26 7.7%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.65.1 69.3%   
Avg P/E ratio x32.051.6 62.0%  
P/CF ratio (eoy) x23.632.9 71.8%  
Price / Book Value ratio x1.73.6 48.3%  
Dividend payout %35.118.2 192.8%   
Avg Mkt Cap Rs m470,2921,360,021 34.6%   
No. of employees `0007.817.8 44.0%   
Total wages/salary Rs m22,50453,671 41.9%   
Avg. sales/employee Rs Th16,899.414,890.9 113.5%   
Avg. wages/employee Rs Th2,877.73,017.1 95.4%   
Avg. net profit/employee Rs Th1,879.91,480.6 127.0%   
INCOME DATA
Net Sales Rs m132,153264,895 49.9%  
Other income Rs m3,1288,388 37.3%   
Total revenues Rs m135,281273,282 49.5%   
Gross profit Rs m66,29056,081 118.2%  
Depreciation Rs m5,20214,998 34.7%   
Interest Rs m44,0975,176 852.0%   
Profit before tax Rs m20,11944,295 45.4%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-9,505 0.0%   
Tax Rs m8,6118,452 101.9%   
Profit after tax Rs m14,70126,338 55.8%  
Gross profit margin %50.221.2 236.9%  
Effective tax rate %42.819.1 224.3%   
Net profit margin %11.19.9 111.9%  
BALANCE SHEET DATA
Current assets Rs m122,742316,359 38.8%   
Current liabilities Rs m310,810198,643 156.5%   
Net working cap to sales %-142.344.4 -320.2%  
Current ratio x0.41.6 24.8%  
Inventory Days Days2395 24.3%  
Debtors Days Days39108 36.1%  
Net fixed assets Rs m116,904213,178 54.8%   
Share capital Rs m3692,399 15.4%   
"Free" reserves Rs m272,161378,606 71.9%   
Net worth Rs m272,530381,006 71.5%   
Long term debt Rs m270,19617,721 1,524.7%   
Total assets Rs m856,261643,028 133.2%  
Interest coverage x1.59.6 15.2%   
Debt to equity ratio x1.00 2,131.6%  
Sales to assets ratio x0.20.4 37.5%   
Return on assets %6.94.9 140.1%  
Return on equity %5.46.9 78.0%  
Return on capital %12.410.0 123.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m15,20040,816 37.2%   
Fx outflow Rs m4,88930,143 16.2%   
Net fx Rs m10,31210,673 96.6%   
CASH FLOW
From Operations Rs m-115,97539,072 -296.8%  
From Investments Rs m-8,265-33,708 24.5%  
From Financial Activity Rs m107,525-15,393 -698.5%  
Net Cashflow Rs m-16,650-7,359 226.3%  

Share Holding

Indian Promoters % 52.9 63.7 83.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 5.1 78.0%  
FIIs % 26.6 23.0 115.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 8.3 198.8%  
Shareholders   93,274 133,026 70.1%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  DISHMAN PHARMA  IPCA LABS  NATCO PHARMA  

Compare PIRAMAL ENTERPRISES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Higher; FMCG and Banking Stocks Gain(12:30 pm)

Stock markets in India are presently trading higher. The BSE Sensex is trading up by 104 points and the NSE Nifty is trading up by 32 points.

Related Views on News

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUN PHARMA has posted a net profit of Rs 15 bn (up 265.5% YoY). Sales on the other hand came in at Rs 77 bn (up 16.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY19); Net Profit Up 21.8% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 21.8% YoY). Sales on the other hand came in at Rs 35 bn (up 22.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

A One Stock Crorepati(Profit Hunter)

Jul 4, 2019

Do you wish you could become a crorepati in the stock market? Read on...

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Jul 17, 2019 01:47 PM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - GLENMARK PHARMA COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS